60 Degrees Pharmaceuticals, Inc. is a leading company based in Washington, DC, dedicated to the development and commercialization of innovative medicines for the treatment and prevention of infectious diseases. With a mission to create vital medicines that can significantly improve and extend people's lives, they are focused on addressing critical research gaps and finding new ways to target infectious diseases, including COVID-19, malaria, babesiosis, fungal diseases, and dengue fever.
Since its establishment in 2010, 60 Degrees Pharmaceuticals has been at the forefront of applying scientific advancements to develop new therapies for infectious diseases. Through collaborations with renowned research institutions, they are committed to finding solutions that enhance the response to infections and provide unprecedented ways to disrupt the lifecycle of parasites. With a strong dedication to meeting global challenges, they are actively advancing clinical trials and developing therapeutic innovations to make a positive impact on the quality of life for those affected by infectious diseases worldwide.
Generated from the website